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From the Home to the Hospital:  The New Bath Salts
Jeanne Zukas, DO; Matthew Cook, DO
A 19-year-old woman nasally insufflated “bath salts” purchased at a 
local truck stop. She presented to an emergency department 12 hours 
later with persistent headache, palpitations, anxiety and insomnia. Vital 
signs revealed blood pressure 152/94 mm Hg, heart rate 131 beats per 
minute, and temperature 100.5 degrees Fahrenheit. EKG revealed sinus 
tachycardia with QRS 82ms and QTc 464ms. The patient was treated 
with intravenous lorazepam and observed. Her symptoms and vital signs 
improved and she was discharged home with family.  Subsequent GC/
MS (gas chromatography mass spectrometry) analysis of the “bath salts” 
specimen provided by the patient indicated the presence of pyrovalerone.
Case
The above presentation is relatively mild compared to more severe 
reactions that have been seen since the drug emerged in the United 
States.  The above case was an early presentation of what would 
become a growing concern in the healthcare community.  
An epidemic of “bath salts” abuse is novel in the U.S., with the drugs 
marketed “not for human consumption” to circumvent the legal statutes 
of the Federal Analog Act. Both drugs were initially unscheduled 
“drugs of concern” according to the U.S Drug Enforcement Agency6.  
As of September 2011 bath salts are classified as illegal through an 
emergency scheduling policy for one year until the DEA makes a 
permanent scheduling decision6.   Bath salt usage among our patients is 
a diagnosis of suspicion or by patient reporting its abuse.   Most cases 
do not have GC/MS analysis as confirmation.  Awareness of the drug 
and its effects is needed to guide its correct diagnosis and treatment.  
More research in needed to fully elucidate the details of this substance.  
SummaryHow Are They Used?
•  Imported primarily from Europe
•  Sold as a powder in head shops, truck stops, convenience stores, 
or online as “bath salts”1.  
• They are taken orally, intravenously, insufflated or by inhalation1,2. 
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Chemical structures:  Erowid.  Erowid.org
The designer drug bath salts are phenylethylamine compounds analogous 
to other amphetamines; they include methylenedioxypyrovalerone (MDPV) 
and 4-methylmethcathinone (mephedrone).  
See chemical structures below and how closely they resemble 
amphetamine structures.  
What are Bath Salts?
Diagnosis
•  Diagnosis is usually made by history given by patient or others. 
•  If use suspected but not given in history, look for drug effects 
which most strongly involve the neurologic, cardiovascular, and 
psychiatric systems3.  
Side Effects
•  Neurologic:   sympathomimetic toxic syndrome, dizziness, 
seizures, decreased motor control3. 
•  Cardiovascular:  “tachycardia, hypertension, vasoconstriction, 
and sweating”4.
•  Psychiatric:   intense drug craving, anxiety, psychosis, agitation, 
insomnia, paranoia, suicidal ideation, changes in perception of 
reality, and reduced ability to think clearly1. 
•  Complications:  rhabdomyolysis, renal failure, liver failure, and 
death3.  
Treatment is similar to that of other stimulant drugs.  Vital signs should be 
monitored for hypertension, hyperthermia, or arrhythmias while laboratory 
screening includes creatine kinase levels5.  Benzodiazepines have 
been used for treatment of violent behavior, seizure, hypertension and 
hyperthermia5.  Avoidance of beta blockers is suggested to avoid rebound 
hypertensive urgency from alpha-adrenergic unopposition5.  Refractory 
symptom management may require use of an antipsychotic such as 
haloperidol or ziprasidone3.
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